Civacir(®) hepatitis C immune globulin broadly neutralizes infection of hepatitis C virus liver graft escape variants and direct-acting antiviral-resistant viruses

Hepatitis C virus (HCV)-induced end-stage liver disease is the major indication for liver transplantation (LT). However, re-infection of the liver graft is still common, especially in patients with detectable viral load at the time of transplantation. Limited data is available with direct-acting ant...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Hepatology
Autori principali: Tawar, Rajiv G., Heydmann, Laura, Schüttrumpf, Jörg, Chavan, Shailesh, Pessaux, Patrick, Habersetzer, François, Bartenschlager, Ralf, Zeisel, Mirjam B., Baumert, Thomas F.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2016
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7615276/
https://ncbi.nlm.nih.gov/pubmed/27531416
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.28767
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi